Pictet Asset Management (Switzerland)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$15.2M Buy
104,628
+15,655
+18% +$2.13M 0.02% 529
2023
Q1
$11.5M Buy
88,973
+691
+0.8% +$86.8K 0.01% 591
2022
Q4
$11.3M Sell
88,282
-658
-0.7% -$76.4K 0.02% 567
2022
Q3
$9.3M Buy
88,940
+835
+0.9% +$91.6K 0.01% 597
2022
Q2
$9.26M Sell
88,105
-360,291
-80% -$42.7M 0.01% 619
2022
Q1
$57.4M Sell
448,396
-24,568
-5% -$2.96M 0.07% 288
2021
Q4
$58.3M Sell
472,964
-7,850
-2% -$1.03M 0.06% 319
2021
Q3
$68.3M Buy
+480,814
New +$70.7M 0.08% 283

Other funds holding ZBH

Pictet Asset Management (Switzerland)'s ZBH Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Zimmer Biomet (ZBH) stake by 18% in Q2 2023, buying an estimated $2.13M and bringing the position to 104,628 shares worth $15.2M. The position accounts for 0.02% of the portfolio, ranked #529.

Pictet Asset Management (Switzerland) first reported a position in ZBH in Q3 2021 and has held it in 8 quarters since. The position peaked at $68.3M in Q3 2021. 1,032 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 104,628 shares of Zimmer Biomet worth $15.2M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 15,655 Zimmer Biomet shares in Q2 2023, an estimated $2.13M.
  • Zimmer Biomet made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #529 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Zimmer Biomet in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Zimmer Biomet position peaked at $68.3M in Q3 2021.
  • 1,032 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.